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A commentary on
Sulfur dioxide contributes to the cardiac and mitochondrial dysfunction in rats
A commentary on Sulfur dioxide contributes to the cardiac and mitochondrial dysfunction in rats  
by Qin G, Meiqiong W, Wang J, Xu Z, Jin X, Sang N. Toxicol Sci (2016). doi: 10.1093/toxsci/kfw048
The article by Qin et al. showed that sulfur dioxide contributes in the impairment of cardiac and 
mitochondrial function in rat H9C2 transformed cardiomyoblasts (1). The authors investigated the 
effect of 10–100 μM sodium bisulfite (NaHSO3) on the mitochondrial function of H2C9 cells and 
rat primary cardiomyocytes and showed that COX activities, Δψm, and ATP content were decreased 
by sulfite (1).
This evidence, though restricted to an in vitro cell model, should raise a fundamental concern 
about sulfite preservatives used in wine industry or food and the consequent role of grapes-derived 
flavonoids in human health. Actually, one of the main sources of sulfites in the human body comes 
from the addition of sulfites and sulfur dioxide to many food products. The pejorative effect of sulfite 
preservatives may dampen the beneficial action of wine polyphenols.
Sulfur dioxide dramatically alters grapes transcriptome, leading to mitochondria impairment 
and downregulation of redox homeostasis (2). Therefore, the presence of sulfur dioxide in plant 
sources represents an important issue for toxicology, besides any further concern about environ-
mental pollutants. Yet, sulfur dioxide in many conventional, purchasable red wines might not alter 
necessarily the yield of flavonoids, such as resveratrol, when compared to sulfite-deprived organic 
wines (3); therefore, its presence or removal should be conventionally reappraised and related to the 
role than sulfites may have on human health. Yet, toxicology of this food preservative shows many 
controversial questions in medicine. Although it was considered as an important risk factor for the 
initiation and progression of liver diseases, based on its proapoptotic and oxidative stressing poten-
tial, molecular research on the apoptotic effect of sub-toxicological doses of sulfur dioxide did not 
appear to fulfill any good expectation, as a controversial debate may occur (4). Figure 1 shows how 
sulfur dioxide, sulfites, and S-sulfonation of proteins may have different effects on mitochondria and 
redox signaling. Yet, severe liver injury and necrotic foci were described with the exposure of sulfur 
dioxide between 56 and 168 mg/m3, i.e., within the range 20–60 ppm (5), though far away from the 
value of 1.5–5.0 ppm, reported by Qin et al. (1). As the same authors addressed in their article, plasma 
level of sulfites closely depends on dietary habits and the composition of human gut microbiome. 
Particularly in Western populations, a dietary regimen made by the presence of saturated fatty acids, 
refined sugars, and low fibers, resembling an experimental milk-derived diet in mice, promotes 
the expansion of sulfite-reducing bacteria, typically Clostridia and other anaerobic species such as 
Deltaproteobacteria, though the profound change in gut microbiome, with increased Bacteroides, 
decreased Firmicutes and a marked change in biliary salt chemistry (6). On the other hand, whey 
retentate, which may come from milk and fermented dairy products (7), promotes the growth 
of symbiontic Bifidobacteria and reduces Bacteroides fragilis and sulfite-reducing Clostridia (8). 
taBle 1 | Sulfur action on cardiac function and oxidative stress.
molecule actions/effects reference
Sulfur 
dioxide
Possible long-term cardiac abnormality Pishgoo et al. (15)
Cardiac and mitochondrial dysfunction (rats) Qin et al. (1)
Increase heart susceptibility to oxidative stress Zaky et al. (16)
Inhibits the proapoptotic effect of 
isopropylarterenol on myocardial tissue through 
a bcl-2/cytc/caspase-9/caspase-3 pathway
Jin et al. (11)
Aggravates myocardial I/R injury Zhang et al. (17)
Sulfur 
dioxide
Ameliorated systemic hypertension and 
pulmonary hypertension prevented the 
development of atherosclerosis and protected 
against myocardial ischemia-reperfusion (I/R) 
injury and isoproterenol-induced myocardial injury
Huang et al. (18)
Sulfites
Sulfur 
mustard
Modification of the ratio prooxidant/antioxidant Shohrati et al. 
(19)Reduction of serum GSH, increase of serum 
malondialdehyde (MDA)
Sulfites Deleterious effects through the mitochondrial 
Fe3+ cyt c-mediated ROS
Velayutham  
et al. (20)
Reduced the length and volume of the 
ventricular capillaries (rats)
Noorafshan  
et al. (21)
With sulfite oxidase contributes in NO signaling Wang et al. (22)
They can affect voltage-gated sodium (Na+) 
channels (VGSC) in a concentration-dependent 
manner in isolated rat ventricular myocytes. 
Protective action of catechins
Wei and 
Meng (23)FIGUre 1 | Cartoon describing some fundamental examples of the 
activity exerted by sulfur (in the form of sulfur dioxide, sulfites, or 
S-proteins) on mitochondria and redox signaling. (a) Sulfites and sulfur 
dioxide are able to inhibit the isopropylarterenol-induced apoptosis and 
mitochondria dysfunction, so exerting a protective potential on myocardial 
activity (11); (B) the same sulfur-possessing molecules may impair 
mitochondria permeability and their ability in producing ATP, then causing 
myocardial dysfunction; (C) sulfite ion impairments of mitochondrial function 
might be explained even with thioredoxin inactivation (12). A mechanistic 
possibility to explain sulfite ion impairment of mitochondrial function is the 
evidence that these ions can inactivate thioredoxin (12) and knowing that the 
thioredoxin 2 system is a major controller of H2O2 emission from mitochondria 
(13), sulfite ions can contribute to increased ROS emission from mitochondria 
that in turn may jeopardize cardiac function; (D) S-sulfonylated proteins, 
containing S-aminoacids, may be source of reactive sulfur species, such as 
cysteine hydropersulfides, which are involved in the metabolism of 
8-nitroguanosine 3′,5′-cyclic monophosphate. This molecule belongs to the 
endogenously formed electrophiles, which are important signaling molecules 
in the ROS and RNS scavenging and regulation (14).
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Gut microbiome is a formidable barrier for the prevention of 
sulfur dioxide entering into the plasma and therefore to reach 
the many target organs, such as myocardial muscle. Furthermore, 
human plasma levels of [SO2]=, often in the form of protein-linked 
S-sulfonate, seem to be better correlated with sulfur dioxide in 
the environmental air, for which an increment of about 1.1 nmol 
of plasma S-sulfonates for any ppm of sulfur dioxide, has been 
reported (9). This would mean that, besides the clearance activ-
ity by human sulfite oxidase (10), sulfur dioxide able to impair 
cardiovascular function and mitochondrial activity should come 
quite exclusively from an inner SO2 saturated microenvironment, 
such as in industrial contexts, despite the considerations that most 
of sulfur would come from diet. Table 1 summarizes some sulfur 
effects. Although the paper by Qin et al. used an in vitro model, 
their conclusion about human health may be quite premature.
The authors used a concentration, expressed into micromoles 
of sodium bisulfite, just approaching the “usual” maximal con-
centration (≈100 μM) coming from daily intake of food and air 
pollution, yet the readers are not allowed to comprehend if this 
apparently “normal” assumption of sulfites may lead to a relevant 
risk of a cardiovascular damage.
The question is which is the possible meaning of the reported 
evidence for human health?
Actually, several organic compounds besides sulfites, such 
as thiosulfates and S-sulfocysteine, also coming from biological 
degradation, may exert a damaging action on mitochondrial 
permeability transition, mitochondria biogenesis, and energy 
homeostasis (24). Sulfites themselves then lead to degenerative 
disorders, e.g., by inhibiting glutamate dehydrogenase in brain 
(25) or causing impairment in kidney functionality (26). The 
observed increase in oxidative stress may derive from an 
impairment in ROS scavenging system, as it is well-known that 
glutathione S-sulfonate, generated from the reaction between 
glutathione disulfide and sulfite, is a competitive inhibitor of 
glutathione-S-transferase (GST), leading to a marked defect in 
the detoxification of xenobiotics. In this context, sulfur is strategic 
in mitochondria-dependent response to oxidative stress, when 
mitochondrial GST can be activated by direct S-thiolation, while 
thiol disulfide exchange depends on the correct glutathione redox 
state. This consideration may suggest that xenobiotics introduced 
with the diet play a major role, probably much more fundamental 
than gaseous SO2, in regulating mitochondria participation in the 
homeostasis of oxidative stressors, probably with the involvement 
of sulfonated-proteins. Actually, an excess of reactive species, also 
from NO and nitrogen, usually coming from an impairment in 
the detoxifying machinery, may lead to peroxynitrite-mediated 
disorder of mitochondrial complex II and peroxynitrite-mediated 
S-sulfonation, exacerbating the risk of myocardial infarction (27). 
The paper by Qin et al. showed a marked inhibition of any mito-
chondrial function by sulfite, probably depending on a different 
contacting area with cell macromolecules by SO2 in the anionic 
and non-gaseous form.
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S-sulfonation is a process by which sulfite interacts with 
proteins; therefore, it may be a very common mechanism in the 
biochemistry of human body, possibly causing pathologies, e.g., 
S-sulfonation of transthyretin has been reported as a trigger step 
in the formation of amyloid fibrils (28). Protein sulfonation, if 
evaluated, may give important further insights.
From a toxicological point of view, dietary intake and cor-
rect information of gut microbiome should be dealt with the 
same emphasis of air pollutants, when addressing plant xeno-
biotics containing sulfur and sulfites present in daily food as 
preservatives.
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